American Fusion Appoints Physicist Dr. Robert V. Duncan as Advisor and Finalizes Testing Framework for Texatron Fusion Engine

American Fusion Inc. (OTC: AMFN) has advanced its fusion energy development program by appointing Dr. Robert V. Duncan as an Independent Scientific and Strategic Advisor and finalizing a comprehensive testing framework for its Texatron Fusion Engine platform. The company announced that Dr. Duncan, a veteran physicist with over three decades of experience in physics research, national laboratories, and university leadership, will provide critical expertise in technology commercialization and research leadership.

The newly completed testing protocol is designed to govern the validation of American Fusion's 5MW Pre-Production Texatron Fusion Engine. The framework supports independent scientific evaluation, incorporating calibrated diagnostics, third-party observation, and public reporting. This structured approach aims to ensure transparency and credibility in the upcoming validation process, which is a key milestone for the company's fusion energy technology.

American Fusion continues to expand its intellectual property portfolio, with additional patent applications covering elements of the Texatron platform. The company recently presented its technology at IEEE ICOPS 2026, engaging with researchers and engineers in the plasma science community. These efforts underscore American Fusion's commitment to advancing its fusion technology and establishing a strong market position.

The appointment of Dr. Duncan brings valuable experience from his work at national laboratories and his role in technology commercialization. His guidance is expected to accelerate American Fusion's path toward commercial fusion energy, addressing one of the most challenging energy problems of our time. The company's stock trades on the OTC market under the symbol AMFN.

For more information about American Fusion Inc., visit the company's newsroom at https://ibn.fm/AMFN.